Response to COMMISSION DELEGATED REGULATION (EU) …/... amending Regulation (EC) No 1234/2008 as regards the examination of variations to the terms of marketing authorisations for medicinal products for human use

28 Feb 2024

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006

23 Oct 2023

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC

23 Oct 2023

Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC

26 Apr 2021

Response to Proposal for Regulation [tbc] on the European Health Data Space, digital health services and products and the use of new technologies, including artificial intelligence (AI) in health

28 Jan 2021

Response to Commission Communication on a Pharmaceutical Strategy- Ensuring sustainable innovation and the availability and affordability of medicines and medical technologies for citizens

1 Jul 2020

Response to Proposal for an EP and Council Regulation on fees charged by the European Medicines Agency (EMA), including remuneration paid to National Competent Authorities (NCAs), for activities related to obtaining and maintaining marketing authorisations for medicinal products for human and veterinary use.

16 Oct 2019

Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis)

17 Oct 2016 · Homeopathic medicines

Meeting with Vytenis Andriukaitis (Commissioner) and 1 other attendee

9 Jul 2015 · Regulatory Framework for Homeopathic/anthroposophic medicines